307 related articles for article (PubMed ID: 32126819)
1. Autonomous Artificial Intelligence in Diabetic Retinopathy: From Algorithm to Clinical Application.
Channa R; Wolf R; Abramoff MD
J Diabetes Sci Technol; 2021 May; 15(3):695-698. PubMed ID: 32126819
[TBL] [Abstract][Full Text] [Related]
2. Artificial Intelligence Algorithms in Diabetic Retinopathy Screening.
Zafar S; Mahjoub H; Mehta N; Domalpally A; Channa R
Curr Diab Rep; 2022 Jun; 22(6):267-274. PubMed ID: 35438458
[TBL] [Abstract][Full Text] [Related]
3. Using artificial intelligence for diabetic retinopathy screening: Policy implications.
Raman R; Dasgupta D; Ramasamy K; George R; Mohan V; Ting D
Indian J Ophthalmol; 2021 Nov; 69(11):2993-2998. PubMed ID: 34708734
[TBL] [Abstract][Full Text] [Related]
4. The SEE Study: Safety, Efficacy, and Equity of Implementing Autonomous Artificial Intelligence for Diagnosing Diabetic Retinopathy in Youth.
Wolf RM; Liu TYA; Thomas C; Prichett L; Zimmer-Galler I; Smith K; Abramoff MD; Channa R
Diabetes Care; 2021 Mar; 44(3):781-787. PubMed ID: 33479160
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.
Wolf RM; Channa R; Abramoff MD; Lehmann HP
JAMA Ophthalmol; 2020 Oct; 138(10):1063-1069. PubMed ID: 32880616
[TBL] [Abstract][Full Text] [Related]
6. ARTEFICIAL INTELLIGENCE IN DIABETIC RETINOPATHY SCREENING. A REVIEW.
Straňák Z; Penčák M; Veith M
Cesk Slov Oftalmol; 2021; 77(5):224-231. PubMed ID: 34666491
[TBL] [Abstract][Full Text] [Related]
7. Artificial Intelligence and Diabetic Retinopathy: AI Framework, Prospective Studies, Head-to-head Validation, and Cost-effectiveness.
Rajesh AE; Davidson OQ; Lee CS; Lee AY
Diabetes Care; 2023 Oct; 46(10):1728-1739. PubMed ID: 37729502
[TBL] [Abstract][Full Text] [Related]
8. Validation of Automated Screening for Referable Diabetic Retinopathy With an Autonomous Diagnostic Artificial Intelligence System in a Spanish Population.
Shah A; Clarida W; Amelon R; Hernaez-Ortega MC; Navea A; Morales-Olivas J; Dolz-Marco R; Verbraak F; Jorda PP; van der Heijden AA; Peris Martinez C
J Diabetes Sci Technol; 2021 May; 15(3):655-663. PubMed ID: 32174153
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence for diabetic retinopathy screening: a review.
Grzybowski A; Brona P; Lim G; Ruamviboonsuk P; Tan GSW; Abramoff M; Ting DSW
Eye (Lond); 2020 Mar; 34(3):451-460. PubMed ID: 31488886
[TBL] [Abstract][Full Text] [Related]
10. [Artificial intelligence for eye care].
Thee EF; Luttikhuizen DT; Lemij HG; Verbraak FD; Sánchez CI; Klaver CCW
Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33331711
[TBL] [Abstract][Full Text] [Related]
11. An overview of artificial intelligence in diabetic retinopathy and other ocular diseases.
Sheng B; Chen X; Li T; Ma T; Yang Y; Bi L; Zhang X
Front Public Health; 2022; 10():971943. PubMed ID: 36388304
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for Progression in Diabetic Retinopathy: Expanding Personalized Medicine through Integration of AI with Electronic Health Records.
Jacoba CMP; Celi LA; Silva PS
Semin Ophthalmol; 2021 May; 36(4):250-257. PubMed ID: 33734908
[TBL] [Abstract][Full Text] [Related]
13. [Using artificial intelligence as an initial triage strategy in diabetic retinopathy screening program in China].
Li ZX; Zhang J; Fong N; He MG
Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(48):3835-3840. PubMed ID: 33371627
[No Abstract] [Full Text] [Related]
14. Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients.
Heydon P; Egan C; Bolter L; Chambers R; Anderson J; Aldington S; Stratton IM; Scanlon PH; Webster L; Mann S; du Chemin A; Owen CG; Tufail A; Rudnicka AR
Br J Ophthalmol; 2021 May; 105(5):723-728. PubMed ID: 32606081
[TBL] [Abstract][Full Text] [Related]
15. Validation of Deep Convolutional Neural Network-based algorithm for detection of diabetic retinopathy - Artificial intelligence versus clinician for screening.
Shah P; Mishra DK; Shanmugam MP; Doshi B; Jayaraj H; Ramanjulu R
Indian J Ophthalmol; 2020 Feb; 68(2):398-405. PubMed ID: 31957737
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence for diabetic retinopathy.
Li S; Zhao R; Zou H
Chin Med J (Engl); 2021 Dec; 135(3):253-260. PubMed ID: 34995039
[TBL] [Abstract][Full Text] [Related]
17. Artificial intelligence for telemedicine diabetic retinopathy screening: a review.
Nakayama LF; Zago Ribeiro L; Novaes F; Miyawaki IA; Miyawaki AE; de Oliveira JAE; Oliveira T; Malerbi FK; Regatieri CVS; Celi LA; Silva PS
Ann Med; 2023; 55(2):2258149. PubMed ID: 37734417
[TBL] [Abstract][Full Text] [Related]
18. ExplAIn: Explanatory artificial intelligence for diabetic retinopathy diagnosis.
Quellec G; Al Hajj H; Lamard M; Conze PH; Massin P; Cochener B
Med Image Anal; 2021 Aug; 72():102118. PubMed ID: 34126549
[TBL] [Abstract][Full Text] [Related]
19. Multicenter, Head-to-Head, Real-World Validation Study of Seven Automated Artificial Intelligence Diabetic Retinopathy Screening Systems.
Lee AY; Yanagihara RT; Lee CS; Blazes M; Jung HC; Chee YE; Gencarella MD; Gee H; Maa AY; Cockerham GC; Lynch M; Boyko EJ
Diabetes Care; 2021 May; 44(5):1168-1175. PubMed ID: 33402366
[TBL] [Abstract][Full Text] [Related]
20. Health Economic and Safety Considerations for Artificial Intelligence Applications in Diabetic Retinopathy Screening.
Xie Y; Gunasekeran DV; Balaskas K; Keane PA; Sim DA; Bachmann LM; Macrae C; Ting DSW
Transl Vis Sci Technol; 2020 Apr; 9(2):22. PubMed ID: 32818083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
